Kras gene mutation analysis

From Aaushi
Jump to navigation Jump to search

Pharmacology

Indications

Laboratory

  • LOINC: 21702-6, 21704-4, 53620-1

More general terms

More specific terms

Additional terms

Component of

References

  1. Lievre A et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008 Jan 20; 26:374. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18202412
  2. Patil DT, Fraser CR, Plesec TP. KRAS testing and its importance in colorectal cancer. Curr Oncol Rep. 2010 May;12(3):160-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20425075
    Tol J, Punt CJ. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther. 2010 Mar;32(3):437-53. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20399983
  3. KRAS Mutation Detection Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0040248.jsp